Skip to main content
SpringerLink
Log in

Timing of intake of lipid lowering drugs: Is that of importance?

  • Pharmakologika: Aktuelles Aus Klinik Und Forschung Der Arzneitherapie
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Brown DD, Schmid J, Long RA, Hull JH (1985) A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules. J Clin Pharmacol 25:360–364

    Google Scholar 

  2. Goldfarb S, Pitot HC (1972) Stimulatory effect of dietary lipid and cholestyramine on hepatic HMG CoA reductase. J Lipid Res 13:797–801

    Google Scholar 

  3. Hanefeld M, Lang PD, Fischer S, Leonhardt W, Bergmann S, Jaross W (1988) Wirkung einer Bezafibrat-Retardzubereitung auf Plasma-Lipoproteine bei Patienten mit Hypercholesterinaemie/Bedeutung des Zeitpunkts der Applikation für die Wirksamkeit. Drug Res 38:1835–1837

    Google Scholar 

  4. Illingworth DR (1986) Comparative efficacy of once versus twice daily mevinolin in the therapy of familial hypercholesterolemia. Clin Pharmacol Ther 40:338–343

    Google Scholar 

  5. Parker TS, McNamara DJ, Brown C, Garrigan O, Kolb R, Batwin H, Ahrens EH (1982) Mevalonic acid in human plasma: Relationship of concentration and circadian rhythm to cholesterol synthesis rates in man. Proc Natl Acad Sci USA 79:3037–3041

    Google Scholar 

  6. Peters JR, Hunninghake DB (1985) Effect of time of administration of cholestyramine on plasma lipids and lipoproteins. Artery 13:1–6

    Google Scholar 

  7. Wuttke H, Papalexiou P, Kaspar FR (1983) Zum optimalen Einnahmezeitpunkt von Lipanthyl R250 Retard Kapseln. Therapiewoche 33:6913–6922

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Stoffwechselkrankheiten und Endokrinopathien, Klinik für Innere Medizin, Medizinische Akademie „Carl Gustav Carus“, Dresden, DDR

    M. Hanefeld

Authors
  1. M. Hanefeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hanefeld, M. Timing of intake of lipid lowering drugs: Is that of importance?. Klin Wochenschr 67, 511–512 (1989). https://doi.org/10.1007/BF01721679

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01721679

Keywords

Search

Navigation